Regeneron Pharmaceuticals
REGN
#299
Rang
€66.19 Md
Capitalisation boursière
624,60 €
Prix de l'action
-1.07%
Changement (1 jour)
-3.60%
Changement (1 an)

Regeneron Pharmaceuticals (REGN) - Dette totale

Dette totale au bilan au Septembre 2025 : 2.27 Milliards d'euros

Selon les derniers rapports financiers de Regeneron Pharmaceuticals, la dette totale de l'entreprise est de 2.27 Milliards d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Regeneron Pharmaceuticals - Dette totale au bilan (de 1996 à 2025)

Dette totale par année

Année Dette totale Changement
2024-12-31€2.59 Md6.29%
2023-12-31€2.44 Md-2.91%
2022-12-31€2.51 Md5.64%
2021-12-31€2.38 Md8.77%
2020-12-31€2.19 Md243.91%
2019-12-31€0.63 Md2.9%
2018-12-31€0.61 Md5.63%
2017-12-31€0.58 Md28.18%
2016-12-31€0.45 Md37.81%
2015-12-31€0.33 Md-11.8%
2014-12-31€0.37 Md3%
2013-12-31€0.36 Md5.68%
2012-12-31€0.34 Md3.09%
2011-12-31€0.33 Md178.75%
2010-12-31€0.12 Md58.11%
2009-12-31€76.09 M1988.76%
2008-12-31€3.64 M-97.34%
2007-12-31€0.13 Md-9.63%
2006-12-31€0.15 Md-10.22%
2005-12-31€0.16 Md14.51%
2004-12-31€0.14 Md-13.19%
2003-12-31€0.16 Md-11.3%
2002-12-31€0.19 Md-15.7%
2001-12-31€0.22 Md7880.4%
2000-12-31€2.84 M-30.15%
1999-12-31€4.07 M15.12%
1998-12-31€3.53 M-25%
1997-12-31€4.71 M-35.63%
1996-12-31€7.33 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
Johnson & Johnson
JNJ
€38.57 Md 1,592.66%🇺🇸 USA
Novartis
NVS
€26.97 Md 1,083.59%🇨🇭 Switzerland
Amgen
AMGN
€45.98 Md 1,917.63%🇺🇸 USA
Sanofi
SNY
€21.50 Md 843.68%🇫🇷 France
Biogen
BIIB
€5.55 Md 143.58%🇺🇸 USA
Alnylam Pharmaceuticals
ALNY
€1.10 Md-51.64%🇺🇸 USA